潜入进展:关于脊柱肌肉缩当前治疗进展的综述
Pankaj Bagga1, Sudhakar Singh1, Gobind Ram2
1School of Bioengineering & Biosciences, Lovely Professional University (LPU), Phagwara, India.
Frontiers in neurology
|June 10, 2024
概括
脊椎肌肉缩 (SMA) 治疗已经显著进步的基因疗法,如 nusinersen,onasemnogene abeparvovec,和risdiplam. 这些疗法向生存运动神经元 (SMN) 基因,改善SMA患者的治疗结果.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 脊椎肌肉缩 (SMA) 是一种遗传性疾病,导致肌肉逐渐衰弱和恶化.
- 以前存在的治疗选择有限,往往导致严重的残疾和过早死亡.
研究的目的:
- 审查脊柱肌肉缩 (SMA) 治疗的最新进展.
- 突出基因向疗法和新型干预措施对患者护理和预后的影响.
主要方法:
- 对基因向疗法的审查,包括nusinersen,onasemnogene abeparvovec和risdiplam.
- 探索小分子化合物和RNA向策略用于SMA治疗.
- 对将科学发现转化为临床益处的合作努力的分析.
主要成果:
- 基因疗法在通过恢复生存运动神经元 (SMN) 蛋白质水平来减缓SMA疾病进展方面表现出前所未有的有效性.
- 小分子和RNA向策略等新的干预措施为SMA治疗提供了多种机制.
- 合作努力加速了SMA研究的临床转化.
结论:
- 最近的治疗进展改变了SMA患者的预后.
- 正在进行的努力重点是提高治疗可访问性,优化策略和改善康复以提高生活质量.
- 针对性治疗的发展为管理脊柱肌肉缩提供了显著的希望.
关键词:
没有任何的 nusinersenersen.在另一种类型的生物中,我们发现了一种类型的生物,它叫做Abeparvovec.康复康复康复康复康复康复里斯迪普拉姆的风险脊柱肌肉缩 脊柱肌肉缩 脊柱肌肉缩生存运动神经元 运动神经元更多相关视频
07:02Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
Published on: May 11, 2018
13.4K
10:57Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons
Published on: July 13, 2015
12.6K
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
01:21Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K